Seoulin Bioscience Co.Ltd Capital Reinvestment Ratio
Seoulin Bioscience Co.Ltd capital reinvestment ratio. Seoulin Bioscience Co.Ltd (038070) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩631.76 Million) in capital expenditures (₩10.90 Million). Check Seoulin Bioscience Co.Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Seoulin Bioscience Co.Ltd (2013–2025)
Capital reinvestment ratio of Seoulin Bioscience Co.Ltd from 2013 to 2025. This chart tracks Seoulin Bioscience Co.Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore Seoulin Bioscience Co.Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Seoulin Bioscience Co.Ltd Capital Reinvestment Ratio by Year (2013–2025)
Seoulin Bioscience Co.Ltd capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see how efficiently does Seoulin Bioscience Co.Ltd generate cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | ₩4.76 Billion | ₩507.47 Million | ▼ -89.8% |
| 2023 | 1.05x | ₩930.57 Million | ₩974.21 Million | ▲ +459.1% |
| 2021 | 0.19x | ₩8.92 Billion | ₩1.67 Billion | ▲ +71.9% |
| 2020 | 0.11x | ₩3.68 Billion | ₩401.34 Million | ▲ +196.1% |
| 2019 | 0.04x | ₩7.32 Billion | ₩269.29 Million | ▼ -62.4% |
| 2018 | 0.10x | ₩4.17 Billion | ₩408.02 Million | ▼ -98.5% |
| 2017 | 6.71x | ₩1.30 Billion | ₩8.73 Billion | ▲ +156.1% |
| 2016 | 2.62x | ₩2.76 Billion | ₩7.21 Billion | ▲ +188.0% |
| 2015 | 0.91x | ₩4.12 Billion | ₩3.74 Billion | ▲ +227.0% |
| 2014 | 0.28x | ₩2.74 Billion | ₩761.57 Million | ▲ +2367.3% |
| 2013 | 0.01x | ₩4.94 Billion | ₩55.65 Million | — |